Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
$BTC: Anthony Pompliano Says ‘In Our Darkest Moment, Bitcoin Steps to the Forefront’
-
Binance Publishes Proof of Reserves System For BTC, More Assets to Follow
-
Cryptos Climb Despite A Firm Dollar And Lingering Fed Fears
-
Why Vitalik Buterin Is ‘Actually Kinda Happy a Lot of the ETFs Are Getting Delayed’
-
Coinbase to Support Bitcoin’s Layer-2 Solution Lightning Network